Sign in Subscribe
COVID-19

New Study on Mycobacterium Tuberculosis Finds Promising Flavonoid Compounds to Combat Disease

Strategic Insights

— 1 min read

Research conducted by University Indonesia has led to a new study on Mycobacterium tuberculosis, highlighting the urgent need to develop new anti-tuberculosis drugs. According to the study, the COVID-19 pandemic has increased awareness about the vulnerability of tuberculosis sufferers to the SARS-CoV-2 virus. With Multidrug Resistant Tuberculosis (MDR-TB) accounting for 78% of the 10 million total cases identified globally, the researchers aimed to explore the potential of flavonoid compounds to counteract antibiotic resistance and enhance the efficacy of existing treatments.

Key Takeaways:

  • The study targeted two flavonoid compounds, quercetin and catechin, derived from Strobilanthes crispus L., to inhibit Mycobacterium tuberculosis target proteins using the AutoDock Vina program.
  • Quercetin was found to be a potent inhibitor of the targeted proteins of M. tuberculosis, producing the highest docking scores of -8.0, -9.2, and -8.0 kcal/mol and inhibition constants of 1.345, 0.177, and 1.345 M for-ketoacyl-ACP Reductase (PDB ID:1UZN), Enoyl-Acyl Carrier Protein Reductase (PDB ID:2X23), and Protein Kinase G (PDB ID:2PZI), respectively.
  • The efficacy of quercetin in inhibiting targeted protein activity warrants further testing.
  • The COVID-19 pandemic has increased awareness about the vulnerability of tuberculosis sufferers to the SARS-CoV-2 virus due to compromised immune systems.
  • Multidrug Resistant Tuberculosis (MDR-TB) accounts for 78% of the 10 million total cases identified globally.

Statistics:

  • 78% - The percentage of total tuberculosis cases worldwide that are Multi-Drug Resistant (MDR-TB)
  • 10 million - The total number of tuberculosis cases identified globally
  • -8.0, -9.2, and -8.0 kcal/mol - The highest docking scores of quercetin for-ketoacyl-ACP Reductase, Enoyl-Acyl Carrier Protein Reductase, and Protein Kinase G, respectively
  • 1.345, 0.177, and 1.345 M - The inhibition constants of quercetin for-ketoacyl-ACP Reductase, Enoyl-Acyl Carrier Protein Reductase, and Protein Kinase G, respectively

Sources:

  • International Journal of Technology (https://doi.org/10.14716/ijtech.v16i3.5620)
  • University Indonesia
  • NewsRx LLC (Copyright 2025)
  • World Health Organization (WHO, 2021)

Read more